Targeting pleckstrin-2/Akt signaling reduces proliferation in myeloproliferative neoplasm models.
Saved in:
| Title: | Targeting pleckstrin-2/Akt signaling reduces proliferation in myeloproliferative neoplasm models. |
|---|---|
| Authors: | Han X; Department of Pathology, Feinberg School of Medicine.; Robert H. Lurie Comprehensive Cancer Center., Mei Y; Department of Pathology, Feinberg School of Medicine.; Robert H. Lurie Comprehensive Cancer Center., Mishra RK; Department of Biochemistry and Molecular Genetics, Feinberg School of Medicine., Bi H; Department of Pathology, Feinberg School of Medicine.; Robert H. Lurie Comprehensive Cancer Center., Jain AD; Department of Chemistry, and., Schiltz GE; Robert H. Lurie Comprehensive Cancer Center.; Department of Chemistry, and.; Department of Pharmacology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA., Zhao B; Department of Pathology, Feinberg School of Medicine.; Robert H. Lurie Comprehensive Cancer Center., Sukhanova M; Department of Pathology, Feinberg School of Medicine.; Robert H. Lurie Comprehensive Cancer Center., Wang P; Department of Pathology, Feinberg School of Medicine., Grigorescu AA; Department of Molecular Biosciences, Weinberg College of Arts & Sciences, Northwestern University, Evanston, Illinois, USA., Weber PC; Harrington Discovery Institute, Cleveland, Ohio, USA., Piwinski JJ; Harrington Discovery Institute, Cleveland, Ohio, USA., Prado MA; Department of Cell Biology, Harvard Medical School, Boston, Massachusetts, USA., Paulo JA; Department of Cell Biology, Harvard Medical School, Boston, Massachusetts, USA., Stephens L; Signaling Programme, The Babraham Institute, Cambridge, United Kingdom., Anderson KE; Signaling Programme, The Babraham Institute, Cambridge, United Kingdom., Abrams CS; Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Yang J; Department of Pathology, Feinberg School of Medicine.; Robert H. Lurie Comprehensive Cancer Center., Ji P; Department of Pathology, Feinberg School of Medicine.; Robert H. Lurie Comprehensive Cancer Center. |
| Source: | The Journal of clinical investigation [J Clin Invest] 2023 Mar 15; Vol. 133 (6). Date of Electronic Publication: 2023 Mar 15. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model: Electronic Cited Medium: Internet ISSN: 1558-8238 (Electronic) Linking ISSN: 00219738 NLM ISO Abbreviation: J Clin Invest Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 36719747 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Targeting pleckstrin-2/Akt signaling reduces proliferation in myeloproliferative neoplasm models. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Han+X%22">Han X</searchLink>; Department of Pathology, Feinberg School of Medicine.; Robert H. Lurie Comprehensive Cancer Center.<br /><searchLink fieldCode="AU" term="%22Mei+Y%22">Mei Y</searchLink>; Department of Pathology, Feinberg School of Medicine.; Robert H. Lurie Comprehensive Cancer Center.<br /><searchLink fieldCode="AU" term="%22Mishra+RK%22">Mishra RK</searchLink>; Department of Biochemistry and Molecular Genetics, Feinberg School of Medicine.<br /><searchLink fieldCode="AU" term="%22Bi+H%22">Bi H</searchLink>; Department of Pathology, Feinberg School of Medicine.; Robert H. Lurie Comprehensive Cancer Center.<br /><searchLink fieldCode="AU" term="%22Jain+AD%22">Jain AD</searchLink>; Department of Chemistry, and.<br /><searchLink fieldCode="AU" term="%22Schiltz+GE%22">Schiltz GE</searchLink>; Robert H. Lurie Comprehensive Cancer Center.; Department of Chemistry, and.; Department of Pharmacology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.<br /><searchLink fieldCode="AU" term="%22Zhao+B%22">Zhao B</searchLink>; Department of Pathology, Feinberg School of Medicine.; Robert H. Lurie Comprehensive Cancer Center.<br /><searchLink fieldCode="AU" term="%22Sukhanova+M%22">Sukhanova M</searchLink>; Department of Pathology, Feinberg School of Medicine.; Robert H. Lurie Comprehensive Cancer Center.<br /><searchLink fieldCode="AU" term="%22Wang+P%22">Wang P</searchLink>; Department of Pathology, Feinberg School of Medicine.<br /><searchLink fieldCode="AU" term="%22Grigorescu+AA%22">Grigorescu AA</searchLink>; Department of Molecular Biosciences, Weinberg College of Arts & Sciences, Northwestern University, Evanston, Illinois, USA.<br /><searchLink fieldCode="AU" term="%22Weber+PC%22">Weber PC</searchLink>; Harrington Discovery Institute, Cleveland, Ohio, USA.<br /><searchLink fieldCode="AU" term="%22Piwinski+JJ%22">Piwinski JJ</searchLink>; Harrington Discovery Institute, Cleveland, Ohio, USA.<br /><searchLink fieldCode="AU" term="%22Prado+MA%22">Prado MA</searchLink>; Department of Cell Biology, Harvard Medical School, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Paulo+JA%22">Paulo JA</searchLink>; Department of Cell Biology, Harvard Medical School, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Stephens+L%22">Stephens L</searchLink>; Signaling Programme, The Babraham Institute, Cambridge, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Anderson+KE%22">Anderson KE</searchLink>; Signaling Programme, The Babraham Institute, Cambridge, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Abrams+CS%22">Abrams CS</searchLink>; Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Yang+J%22">Yang J</searchLink>; Department of Pathology, Feinberg School of Medicine.; Robert H. Lurie Comprehensive Cancer Center.<br /><searchLink fieldCode="AU" term="%22Ji+P%22">Ji P</searchLink>; Department of Pathology, Feinberg School of Medicine.; Robert H. Lurie Comprehensive Cancer Center. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%227802877%22">The Journal of clinical investigation</searchLink> [J Clin Invest] 2023 Mar 15; Vol. 133 (6). <i>Date of Electronic Publication: </i>2023 Mar 15. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+for+Clinical+Investigation%22">American Society for Clinical Investigation </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7802877 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1558-8238 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200219738%22">00219738 </searchLink><i>NLM ISO Abbreviation: </i>J Clin Invest <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36719747 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1172/JCI159638 Languages: – Code: eng Text: English Titles: – TitleFull: Targeting pleckstrin-2/Akt signaling reduces proliferation in myeloproliferative neoplasm models. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Han X – PersonEntity: Name: NameFull: Mei Y – PersonEntity: Name: NameFull: Mishra RK – PersonEntity: Name: NameFull: Bi H – PersonEntity: Name: NameFull: Jain AD – PersonEntity: Name: NameFull: Schiltz GE – PersonEntity: Name: NameFull: Zhao B – PersonEntity: Name: NameFull: Sukhanova M – PersonEntity: Name: NameFull: Wang P – PersonEntity: Name: NameFull: Grigorescu AA – PersonEntity: Name: NameFull: Weber PC – PersonEntity: Name: NameFull: Piwinski JJ – PersonEntity: Name: NameFull: Prado MA – PersonEntity: Name: NameFull: Paulo JA – PersonEntity: Name: NameFull: Stephens L – PersonEntity: Name: NameFull: Anderson KE – PersonEntity: Name: NameFull: Abrams CS – PersonEntity: Name: NameFull: Yang J – PersonEntity: Name: NameFull: Ji P IsPartOfRelationships: – BibEntity: Dates: – D: 15 M: 03 Text: 2023 Mar 15 Type: published Y: 2023 Identifiers: – Type: issn-electronic Value: 1558-8238 Numbering: – Type: volume Value: 133 – Type: issue Value: 6 Titles: – TitleFull: The Journal of clinical investigation Type: main |
| ResultId | 1 |